Acquisition - January 9, 2015
Companies Reach Commercialization Deal
Helsinn Group and Denmark’s Pharmacosmos A/S announced that they have reached an agreement for the exclusive U.S. commercialization rights to Monofer®, an innovative intravenous iron replacement therapy under development for the treatment of Iron Deficiency Anemia. Helsinn received the exclusive rights to commercialize Monofer® and any other iron isomaltoside 1000 products developed by Pharmacosmos in the […]
Acquisition - January 7, 2015
Novo Renews Racing Pact
Novo Nordisk and the Chip Ganassi Racing Teams (CGRT) have inked a multi-year extension of their partnership, renewing Novo Nordisk as the primary sponsor of the No. 83 Novo Nordisk Chip Ganassi Racing entry, driven by Charlie Kimball in the Verizon IndyCar Series. Kimball, 29, from Camarillo, California, is the first and only licensed driver with diabetes […]
Acquisition - November 25, 2014
AZ Plans U.S. Expansion
AstraZeneca plans to kick off a U.S. expansion anticipated to add 300 jobs so it can capitalize on a pipeline full of strong candidates, which it is counting on to help return the company to growth by 2017. “Our global biologics research and development arm, MedImmune, has a robust pipeline of more than 120 biologics, […]
Acquisition - November 18, 2014
Recipharm Buys Lusomedicameta
The Swedish Pharmaceutical Contract Development and Manufacturing Organisation Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A. for SEK 1 billion. The transaction values Lusomedicamenta at an enterprise value of EUR 112.3 million (SEK 1 040 million), which represents an adjusted EBITDA multiple of 8.8 based on LTM September 2014. The […]
Acquisition - November 7, 2014
MedImmune Acquires Definiens
MedImmune, AstraZeneca’s global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has developed an imaging and data analysis technology known as Tissue Phenomics™. The new technology significantly improves the identification of biomarkers in tumor tissue. According to the agreement, MedImmune will acquire 100 percent of Definiens’ […]
Acquisition - November 4, 2014
LabCorp to Acquire Covance
Laboratory Corporation of America (LH), also known as LabCorp, plans to acquire Covance (CVD) for $6.1 billion. Covance, a CRO that provides services for drug development and animal testing, is based in Princeton, NJ (US). LabCorp is the second largest clinical diagnostic company in the U.S. Acquiring Covance will help LabCorp access a larger international […]
